Rotavirus, Vaccine and Unanswered Questions: A Perspective from a Least Developed Country

  • Sher Bahadur Pun Clinical Research Unit, Sukraraj Tropical and Infectious Disease Hospital, Kathmandu, Nepal

Abstract

Two rotavirus vaccines, RotaTeq (Merck) and Rotarix (GlaxoSmithKline) have been developed
to neutralize the most common rotavirus serotypes, and are now available in the global market.
These vaccines are primarily aimed at reducing rotavirus gastroenteritis in children in the least
developed countries, where rotavirus mortality rate is believed to be greatest. Thus, the World
Health Organization (WHO) has recommended rotavirus vaccination be included in all national
immunization programs, while the least developed countries have so far not come up with clear
vision and long term strategy on vaccine implementation, and several questions, in addition to this,
remain unanswered.
_______________________________________________________________________________________
Keywords: least developed country; rotavirus; vaccines.

Published
2013-07-01
How to Cite
Pun, S. (2013). Rotavirus, Vaccine and Unanswered Questions: A Perspective from a Least Developed Country. Journal of Nepal Medical Association, 52(191). https://doi.org/10.31729/jnma.2286
Section
Viewpoint